Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Deraco

Showing results (111-120 of 178) with videos related to

Pageof 18
Sort By:
World Journal of Gastrointestinal Oncology|December 17, 2010
Experience with peritoneal mesothelioma at the Milan National Cancer InstituteMarcello Deraco, Dario Baratti, Antonello Domenico Cabras, et al.
American Journal of Surgery|March 1, 2002
Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanomaStefano Guadagni, Filippo Russo, Carlo Riccardo Rossi, et al.
Cancers|April 14, 2025
Clinical and Pathological Risk Factors for Peritoneal Metastases in a Surgical Series of T4 Colorectal CancersDario Baratti, Carlo Galdino Riva, Marcello Guaglio, et al.
Journal of Surgical Oncology|October 9, 2018
Erratum: Re: The American Society of Peritoneal Surface Malignancies Multi-Institution Evaluation of 1,051 Advanced Ovarian Cancer Patients Undergoing Cytoreductive Surgery and HIPEC: An Introduction of the Peritoneal Surface Disease Severity Score. Journal of Surgical Oncology 2016;114(7):779-784Jason M Foster, Richard Sleightholm, Lynette Smith, et al.
Minerva Chirurgica|May 8, 2019
Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: a retrospective studyStefano Guadagni, Giammaria Fiorentini, Paola Palumbo, et al.
Annals of Surgical Oncology|August 14, 2016
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal MetastasesDario Baratti, Shigeki Kusamura, Domenico Iusco, et al.
Journal of Surgical Oncology|September 25, 2024
Education and Training in Peritoneal Surface OncologySantiago González-Moreno, Marcello Deraco, Shigeki Kusamura, et al.
Melanoma Research|February 6, 2003
Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot studyStefano Guadagni, Mario Santinami, Roberto Patuzzo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2017
Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyArmando Sardi, Arkadii Sipok, Dario Baratti, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|November 23, 2007
Survivin is highly expressed and promotes cell survival in malignant peritoneal mesotheliomaNadia Zaffaroni, Aurora Costa, Marzia Pennati, et al.
Pageof 18

Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
World Journal of Gastrointestinal Oncology|December 17, 2010
Experience with peritoneal mesothelioma at the Milan National Cancer InstituteMarcello Deraco, Dario Baratti, Antonello Domenico Cabras, et al.
American Journal of Surgery|March 1, 2002
Deliberate hypoxic pelvic and limb chemoperfusion in the treatment of recurrent melanomaStefano Guadagni, Filippo Russo, Carlo Riccardo Rossi, et al.
Cancers|April 14, 2025
Clinical and Pathological Risk Factors for Peritoneal Metastases in a Surgical Series of T4 Colorectal CancersDario Baratti, Carlo Galdino Riva, Marcello Guaglio, et al.
Journal of Surgical Oncology|October 9, 2018
Erratum: Re: The American Society of Peritoneal Surface Malignancies Multi-Institution Evaluation of 1,051 Advanced Ovarian Cancer Patients Undergoing Cytoreductive Surgery and HIPEC: An Introduction of the Peritoneal Surface Disease Severity Score. Journal of Surgical Oncology 2016;114(7):779-784Jason M Foster, Richard Sleightholm, Lynette Smith, et al.
Minerva Chirurgica|May 8, 2019
Hypoxic pelvic perfusion with cisplatin and mitomycin C in multidisciplinary palliative treatment of patients with unresectable recurrent rectal cancer: a retrospective studyStefano Guadagni, Giammaria Fiorentini, Paola Palumbo, et al.
Annals of Surgical Oncology|August 14, 2016
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal MetastasesDario Baratti, Shigeki Kusamura, Domenico Iusco, et al.
Journal of Surgical Oncology|September 25, 2024
Education and Training in Peritoneal Surface OncologySantiago González-Moreno, Marcello Deraco, Shigeki Kusamura, et al.
Melanoma Research|February 6, 2003
Hypoxic pelvic and limb perfusion with melphalan and mitomycin C for recurrent limb melanoma: a pilot studyStefano Guadagni, Mario Santinami, Roberto Patuzzo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 3, 2017
Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapyArmando Sardi, Arkadii Sipok, Dario Baratti, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|November 23, 2007
Survivin is highly expressed and promotes cell survival in malignant peritoneal mesotheliomaNadia Zaffaroni, Aurora Costa, Marzia Pennati, et al.
Pageof 18